The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing

Biomaterials

Volumn 28, Issue 6, 2007, Pages 1280-1288

  Liu, Xiudong ^a   Howard, Kenneth A ^a   Dong, Mingdong ^a   Andersen, Morten Ø ^a   Rahbek, Ulrik L ^a   Johnsen, Mads G ^b   Hansen, Ole C ^b   Besenbacher, Flemming ^a   Kjems, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b BIONEER A S   (Denmark)

Author keywords

Chitosan; Delivery; Gene silencing; Nanoparticle; RNA interference; siRNA

Indexed keywords

BIOMATERIALS; CELLS; GENES; MOLECULAR WEIGHT; NANOSTRUCTURED MATERIALS; POLYMERS;

CHITOSAN; GENE SILENCING; RNA INTERFERENCE; SIRNA; ZETA POTENTIAL;

RNA;

CHITOSAN; ENHANCED GREEN FLUORESCENT PROTEIN; POLYMER; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CORRELATION ANALYSIS; DEACETYLATION; DRUG FORMULATION; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MORPHOLOGY; NANOPARTICLE; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; GENE SILENCING; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; PARTICLE SIZE; RNA, SMALL INTERFERING;

EID: 33751419974     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.11.004     Document Type: Article

References (40)

1. Plasterk R.H. RNA silencing: the genome's immune system. Science 296 (2002) 1263-1265
2. Milhavet O., Gary D.S., and Mattson M.P. RNA interference in biology and medicine. Pharmacol Rev 55 4 (2003) 629-648
3. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
4. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
5. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
6. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3 (2004) 318-329
7. Pouton C.W., and Seymour L.W. Key issues in non-viral gene delivery. Adv Drug Deliver Rev 46 (2001) 187-203
8. Xia H.B., Mao Q.W., Paulson H.L., and Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20 (2002) 1006-1010
9. Barton G.M., and Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. PNAS 99 23 (2002) 14943-14945
10. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol 21 3 (2003) 117-122
11. Soutschek J., Akinc A., Bramlage B., Charisse K., ZConstien R., Donoghue M., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
12. Ichim T.E., Li M., Qian H., Popov I.A., Rycerz K., Zheng X.F., White D., Zhong R., and Min W.P. RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant 4 (2004) 1227-1236
13. Schiffelers R.M., Ansari A., Xu J., Zhou Q., Tang Q.Q., Storm G., et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 32 19 (2004) e149
14. Bitko V., Musiyenko A., Shulyayeva O., and Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 11 1 (2005) 50-55
15. Borchard G. Chitosans for gene delivery. Adv Drug Deliver Rev 52 (2001) 145-150
16. Liu W.G., and Yao K.D. Chitosan and its derivatives-a promising non-viral vector for gene transfection. J Control Release 83 (2002) 1-11
17. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., and Fernandes J.C. Chitsoan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 57 (2004) 1-8
18. Richardson S.C.W., Kolbe H.V.J., and Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 178 (1999) 231-243
19. Corsi K., Chellat F., Yahia L., and Fernandes J.C. Mesenchymal stem cells, MG63 and HEK 293 transfection using chitosan-DNA nanoparticles. Biomaterials 24 (2003) 1255-1264
20. Chandy T., and Sharma C.P. Chitosan-as a biomaterial. Biomater Artif Cell Artif Organ 18 (1990) 1-24
21. Illum L., Farraj N.F., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 11 (1994) 1186-1189
22. Verhoef J.C., Junginger H.E., and Thanou M. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliver Rev 50 (2001) S91-S101
23. Carreño-Gómez B., and Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 148 (1997) 231-240
24. Mao H.Q., Roy K., Truong-Le V.L., Janes K.A., Lin K.Y., Wang Y., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70 (2001) 399-421
25. Li X.W., Lee D.K.L., Chan A.S.C., and Alpar H.O. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochim Biophys Acta 1630 (2003) 7-18
26. Köping-Höggård M., Vårum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., and Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther 11 (2004) 1441-1452
27. Kiang T., Wen J., Lim H.W., and Leong K.W. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 25 (2004) 5293-5301
28. Liu W.G., Sun S.J., Cao Z.Q., Zhang X., Yao K.D., Lu W.W., et al. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials 26 (2005) 2705-2711
29. Howard K.A., Rahbek U.L., Liu X.D., Damgaard C.K., Glud S.Z., Anderson M.Ø., et al. RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol Ther 14 (2006) 476-484
30. Vårum K.M., Ottøy M.H., and Smidsrød O. Water-solubility of partially N-acetylated chitosan as a function of pH: effect of chemical composition and depolymerization. Carbohydr Polym 25 (1994) 65-70
31. Ottøy M.H., Vårum K.H., Christensen B.E., Anthonsen M.W., and Smidsrød O. Preparative and analytical size-exclusion chromatography of chitosans. Carbohydr Polym 31 (1996) 253-261
32. Hirano S., Ohe Y., and Ono H. Selective N-acetylation of chitosan. Carbohydr Res 47 (1976) 315-320
33. Muzzarelli R.A.A., and Rocchetti R. Determination of the degree of acetylation of chitosans by first derivative ultraviolet spectrophotometry. Carbohydr Polym 5 (1985) 461-472
34. Khan T.A., Peh K.K., and Ch'ng H.S. Reporting degree of deacetylation values of chitosan: the influence of analytical methods. J Pharm Pharm Sci 5 (2002) 205-212
35. www.imgemet.com
36. Sato T., Ishii T., and Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22 (2001) 2075-2080
37. MacLaughlin F.C., Mumper R.J., Wang J.J., Tagliaferri J.M., Gill I., Hinchcliffe M., et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 56 (1998) 259-272
38. Doench J., Petersen C., and Sharp P. siRNAs can function as miRNAs. Genes Dev 17 (2003) 438-442
39. Huang M., Fong C.W., Khor E., and Lim L.Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Control Release 106 (2005) 391-406
40. Ishii T., Okahata Y., and Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 1514 (2001) 51-64